Vimarsana
Biggest News Aggregation in the World

Reference Tocilizumab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reference Tocilizumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reference Tocilizumab Today - Breaking & Trending Today

Dr. Reddy's Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab - Vimarsana News

Dr. Reddy's Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab

Published: June 5, 2023

Tocilizumab is an important anti-rheumatic agent used in the treatment of adult patients with moderate to severe active rheumatoid arthritis who have had an inadequate response to one or more... | June 5, 2023

Source: marketscreener.com
Related Topics:
United StatesAndhra PradeshReddy TocilizumabJayanth SridharTocilizumab RoactemraTocilizumab ActemraReddy Laboratories LtdExchange CommissionChugai Seiyaku Kabushiki Kaisha CorpGood Health Cant WaitRoche GroupDouble BlindComparative PharmacokineticPharmacodynamic StudyReference TocilizumabIntravenous RouteNormal Healthy Male VolunteerGlobal HeadGood Health Cant WaitSustainability ReportAnnual ReportDr Reddys Laboratories Limited Stock ExchangePress ReleaseOr 500124 Ine089a01023
Dr. Reddy's successfully completes Phase I study (IV route) of DRL_TC, a proposed biosimilar of tocilizumabp - Vimarsana News

Dr. Reddy's successfully completes Phase I study (IV route) of DRL_TC, a proposed biosimilar of tocilizumabp

Published: June 5, 2023

Dr. Reddy's Laboratories Ltd. , a global pharmaceutical company, announced that its tocilizumab biosimilar candidate, DRL_TC, successfully met its primary and secondary endpoints in a Phase I study.

Source: equitybulls.com
Related Topics:
United StatesReddy TocilizumabTocilizumab RoactemraTocilizumab ActemraJayanth SridharReddy LaboratoriesReddy Laboratories LtdDouble BlindComparative PharmacokineticPharmacodynamic StudyReference TocilizumabIntravenous RouteNormal Healthy Male VolunteerGlobal HeadLaboratories Limited